help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, Q.-Y.
Right arrow Articles by Maclaren, N. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Q.-Y.
Right arrow Articles by Maclaren, N. K.
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 4 1545-1549
Copyright © 2000 by The Endocrine Society


Original Studies

The Human Leukocyte Antigen HLA DRB3*0202/DQA1*0501 Haplotype Is Associated with Graves’ Disease in African Americans

Qiao-Yi Chen, David Nadell, Xian-Yang Zhang, Anjli Kukreja, Yao-Jin Huang, Jonathan Wise, Frank Svec, Robert Richards, Karen E. Friday, Alfonso Vargas, Ricardo Gomez, Stuart Chalew, Michael S. Lan, Yaron Tomer and Noel K. Maclaren1

The Research Institute for Children (Q.-Y.C., D.N., X.-Y.Z., A.K., Y.-J.H., A.V., R.G., S.C., M.L., N.K.M.), Children’s Hospital, Harahan, Louisiana 70123; Departments of Pediatrics (Q.-Y.C., A.K., A.V., R.G., S.C., M.S.L., N.K.M.) and Medicine (F.S.), LSUMS, New Orleans, Louisiana 70112; Institute for the Treatment of Diabetes and Metabolism (J.W.), Methodist Hospital, New Orleans, Louisiana 70127; Department of Medicine (R.R., K.E.F.), Tulane University Medical Center, New Orleans, Louisiana 70112; and Division of Endocrinology and Metabolism (Y.T.), Mount Sinai School of Medicine, New York, New York 10029

Address correspondence and requests for reprints to: Noel K. Maclaren, M.D., Director, Research Institute for Children, 520 Elmwood Park Boulevard, Suite 160, Harahan, Louisiana 70123. E-mail: nkmaclaren{at}aol.com

Information on genetic susceptibility to Graves’ disease in African Americans is limited. We studied DRB1, DQB1, DRB3 subtypes, DQA1*0501, DQA1*0201, and CTLA-4 polymorphisms in 49 African American patients with adult onset Graves’ disease and 47 racially-matched controls using PCR-based sequence-specific priming methods. There were no significant differences in DRB1 or DQB1 allelic frequencies or CTLA-4 polymorphisms between patients and controls. However, we found that the frequency of DRB3 was significantly increased in the patients (75.5% vs. 57.4%, P = 0.006, X2 = 3.52), especially for the DRB3*0202 subtype (53.1% vs. 23.4, P = 0.003, X2 = 8.91). In this one respect, the finding was in concordance with our previous observations in Caucasian patients with adult-onset Graves’ disease. In addition, whereas the frequency of DQA1*0501 was increased (P = 0.018, X2 = 5.63) in our patients, the haplotype of DRB3/DQA1*0501, or DRB3*0202/DQA1*0501 was found to be more strongly associated (P = 0.008, X2 = 7.0; P = 0.0008, X2 = 11.34, respectively). These data suggest that DRB3*0202, particularly when found with DQA1*0501 in a haplotype is a susceptible gene(s) for Graves’ disease in adult African Americans. Considering these data with those in Caucasian patients, our results would suggest that the primary Graves susceptible locus is likely DRB3 and not DRB1.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
F. K. Kavvoura, T. Akamizu, T. Awata, Y. Ban, D. A. Chistiakov, I. Frydecka, A. Ghaderi, S. C. Gough, Y. Hiromatsu, R. Ploski, et al.
Cytotoxic T-Lymphocyte Associated Antigen 4 Gene Polymorphisms and Autoimmune Thyroid Disease: A Meta-Analysis
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3162 - 3170.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
Y. Tomer and T. F. Davies
Searching for the Autoimmune Thyroid Disease Susceptibility Genes: From Gene Mapping to Gene Function
Endocr. Rev., October 1, 2003; 24(5): 694 - 717.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Dittmar and G. J. Kahaly
Polyglandular Autoimmune Syndromes: Immunogenetics and Long-Term Follow-Up
J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 2983 - 2992.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Vaidya, P. Kendall-Taylor, and S. H. S. Pearce
The Genetics of Autoimmune Thyroid Disease
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5385 - 5397.
[Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. Alkhateeb, G. L. Stetler, W. Old, J. Talbert, C. Uhlhorn, M. Taylor, A. Fox, C. Miller, D. G. Dills, E. C. Ridgway, et al.
Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2
Hum. Mol. Genet., March 1, 2002; 11(6): 661 - 667.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Ten, M. New, and N. Maclaren
Addison's Disease 2001
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 2909 - 2922.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society